• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

Rapid genetic testing useful for diagnosis of critically ill children

byStephanie Harlow, MDandLeah Carr, MD
September 22, 2017
in Uncategorized
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. In a cohort of children under the age of 12 months admitted to the intensive care unit (ICU) without a clear diagnosis, rapid, targeted genetic testing revealed a diagnosis in about one-third of patients.

2. Genetic diagnoses significantly impacted the care of those children identified as having a genetic mutations, leading to removal of unnecessary treatment in a number of children.

Study Rundown: Timely diagnosis of genetic diseases in severely ill children can be difficult and lengthy, yet definitive diagnoses are often critical. In this study, researchers used rapid whole genome sequencing (WGS) to analyze specific genes as part of the diagnostic work up in infants under age 1 admitted to the ICU. This study included critically ill infants with clinical suspicion of a genetic disease, but without a clear diagnosis. Patients identified as “critically ill” included infants with cardiorespiratory insufficiency requiring a ventilator or organ dysfunction which was thought to have imminent risk for cardiorespiratory insufficiency. The team assessed diagnostic yield, speed of results, and the effect of WGS on clinical management. Variants discovered after WGS were filtered through a number of genetic databases for assessment of minor alleles, and variants remaining were evaluated manually by investigators. Of the infants included in the study, about one-third were identified as having a genetic mutation as the cause of their presenting illness. In the majority of children with identified mutations, unsuccessful intensive therapies were withdrawn following diagnosis. The study was limited by its small sample size and completion at a single center, but demonstrates the potential clinical utility of rapid WGS to efficiently diagnose suspected genetic syndromes.

Click here to read the original article, published today in Pediatrics

Relevant Reading: Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings

In-Depth [prospective pilot study]: This study assessed 23 infants under age 1 admitted to the NICU/PICU who were critically ill. Included patients lacked a definitive diagnosis, though a genetic etiology was suspected. Of those infants included, 6 presented with abnormal muscle tone, 5 with severe seizures, 4 with cardiomyopathy, 3 with liver failure, 2 with microcephaly, 1 with leukoencephalopathy-induced coma, 1 with multiple congenital anomalies, and 1 with interstitial lung disease. Measured endpoints included diagnostic yield, speed of turnaround, and clinical effect of the results. Turnaround was defined as the period of time starting when the patient was initiated into the study and ended with provisional diagnosis. After WGS was completed, specific genes were analyzed based on known clinical significance of some 3300 mutations documented in the Clinical Genome Database. Sequenced genes under investigation were assess using Human Phenotype Ontology (HPO) terms, and the presence of minor alleles was assessed using data from 5 previously established databases. Seven of the 23 infants included received a genetic diagnosis, with the turnaround time ranging from 5 to 23 days for diagnosis (median = 12). Diagnoses included Vici syndrome, combined oxidative phosphorylation deficiency-11, and vanishing white matter, nemaline myopathy, progressive mitochondrial myopathy, and GM1-gangliosidosis, and a 1p36.33p36.32 microdeletion. Five of the 7 diagnosed patients had unsuccessful care withdrawn following the identification of their underlying genetic disorder.

RELATED REPORTS

Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography

Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Risk of death and cardiac arrest during triathlon may be higher in older males

Next Post

Adverse outcomes are similar for patients undergoing percutaneous coronary intervention receiving heparin or bivalirudin

RelatedReports

A sleeping child with electrodes on the scalp, surrounded by a moon and night sky, illustrating sleep monitoring and brain health assessment.
Artificial Intelligence

Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography

October 19, 2026
A surgical tray with instruments, balanced scales indicating cost, and monetary coins, symbolizing the economics of surgery and complication management.
Gastroenterology

Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy

October 19, 2026
Depiction of a brain with highlighted areas of activity next to a hand reaching towards a pain signal, alongside an MRI machine, suggesting investigation of pain perception mechanisms.
Chronic Disease

A reduced length protocol for peripheral magnetic stimulation may be as effective compared to standard length protocol for upper trapezius myofascial pain syndrome

October 18, 2026
An illustration showcasing knee anatomy, rehabilitation exercises with a resistance band, and surgical instruments on a tray, emphasizing meniscus therapy and surgery.
Orthopedic Surgery

Preoperative self-preparation for total knee arthroplasty is multifactorial and can be optimized by targeting external support and internal motivation

October 17, 2026
Next Post

Adverse outcomes are similar for patients undergoing percutaneous coronary intervention receiving heparin or bivalirudin

Thyrotropin and free T4 levels associated with life expectancy and risk of cardiovascular disease

Adiponectin treats some symptoms of polycystic ovarian syndrome in mice [PreClinical]

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography
  • Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy
  • A reduced length protocol for peripheral magnetic stimulation may be as effective compared to standard length protocol for upper trapezius myofascial pain syndrome
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.